Bulletin No. 2, 2021

12 Chinese University Bulletin No.2, 2021 Sowing the Seeds of Change In recent years, Hong Kong has been enjoying globally leading strengths in the innovative biomedicine sector. Since its reform of listing rules to allow pre-revenue biotechnology companies to raise capital in 2018, Hong Kong has become the world’s number two biotech funding hub. The city’s sophisticated medical research system, combined with a sound protection mechanism for intellectual property rights and international recognition of clinical data, bestows on it distinctive strengths that no other city in the GBA can rival. The ability to seize opportunities and adjust its focus towards embracing global trends and challenges of the new era has paved the way for CUHK’s success. CUHK 2025 , the latest Strategic Plan of CUHK, reflects the University’s commitment to research and Seizing opportunities with ‘plans’